The effect of CCND1 +870A>G and VEGF +936C>T polymorphisms on oral cancer development and disease-free survival in a Taiwan population

Oral Oncology

Volumn 48, Issue 6, 2012, Pages 535-540

  Lin, Ying Chu ^a,b   Yeh, Chia Jung ^a   Wang, Li Hsuan ^b   Lee, Chia Wen ^a   Chen, Chung Ho ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cyclin D1 (CCND1); Disease free survival; Hazard risk; Oral cancer; Polymorphisms; Vascular endothelial growth factor (VEGF)

Indexed keywords

CYCLIN D1; VASCULOTROPIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; SEX DIFFERENCE; TAIWAN;

ADULT; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYCLIN D1; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TAIWAN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862832389     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.01.008     Document Type: Article

References (35)

1. J.N. Al-Swiahb, C.H. Chen, H.C. Chuang, F.M. Fang, H.T. Tasi, and C.Y. Chien Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity Future Oncol 6 5 2010 837 850
2. Department of Health R Health and vital statistics, Republic of China 2008 2010 Department of Health, Executive Yuan Taipei, ROC
3. H. Myoung, M.J. Kim, J.H. Lee, Y.J. Ok, J.Y. Paeng, and P.Y. Yun Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients Int J Oral Maxillofac Surg 35 11 2006 1005 1010
4. R.W. Hinerman, W.M. Mendenhall, C.G. Morris, R.J. Amdur, J.W. Werning, and D.B. Villaret Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience Head Neck 26 11 2004 984 994
5. S. Johnstone, and R.M. Logan The role of vascular endothelial growth factor (VEGF) in oral dysplasia and oral squamous cell carcinoma Oral Oncol 42 4 2006 337 342
6. R.S. Kerbel Tumor angiogenesis N Engl J Med 358 19 2008 2039 2049
7. Y.H. Kim, S.M. Kim, Y.K. Kim, S.P. Hong, M.J. Kim, and H. Myoung Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma J Oral Pathol Med 39 5 2010 368 375
8. J. Mrena, J.P. Wiksten, A. Kokkola, S. Nordling, A. Ristimaki, and C. Haglund COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer Tumour Biol 31 1 2010 1 7
9. B.P. Schneider, M. Radovich, and K.D. Miller The role of vascular endothelial growth factor genetic variability in cancer Clin Cancer Res 15 17 2009 5297 5302
10. F. de Nigris, V. Crudele, A. Giovane, A. Casamassimi, A. Giordano, and H.J. Garban CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy Proc Natl Acad Sci U S A 107 32 2010 14484 14489
11. W. Renner, S. Kotschan, C. Hoffmann, B. Obermayer-Pietsch, and E. Pilger A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels J Vasc Res 37 6 2000 443 448
12. B. Xu, J.M. Li, N. Tong, J. Tao, P.C. Li, and N.H. Song VEGFA +936C>T polymorphism and cancer risk: a meta-analysis Cancer Genet Cytogenet 198 1 2010 7 14
13. P. Gill, A.J. Jeffreys, and D.J. Werrett Forensic application of DNA 'fingerprints' Nature 318 6046 1985 577 579
14. Y.C. Lin, H.I. Huang, L.H. Wang, C.C. Tsai, O. Lung, and C.Y. Dai Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population Oral Oncol 44 8 2008 798 804
15. K.E. Knudsen, J.A. Diehl, C.A. Haiman, and E.S. Knudsen Cyclin D1: polymorphism, aberrant splicing and cancer risk Oncogene 25 11 2006 1620 1628
16. K.M. Sathyan, K.R. Nalinakumari, T. Abraham, and S. Kannan Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility Oral Oncol 42 6 2006 607 613
17. C. Tang, Z. Wang, J. Yu, Y. Wu, Z. Zhu, and N. Chen CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis Med Oncol 2010 10.1007/s12032-010-9547-7
18. M.H. Tsai, C.W. Tsai, Y.A. Tsou, C.H. Hua, C.F. Hsu, and D.T. Bau Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in taiwan Anticancer Res 31 1 2011 227 231
19. Y.K. Wong, S.C. Lin, C.S. Chang, Y.H. Tseng, C.J. Liu, and H.C. Lin Cyclin D1 genotype in areca-associated oral squamous cell carcinoma J Oral Pathol Med 32 5 2003 265 270
20. S.L. Holley, C. Matthias, V. Jahnke, A.A. Fryer, R.C. Strange, and P.R. Hoban Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma Oral Oncol 41 2 2005 156 160
21. M. Rydzanicz, P. Golusinski, D. Mielcarek-Kuchta, W. Golusinski, and K. Szyfter Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx Eur Arch Otorhinolaryngol 263 1 2006 43 48
22. C. Matthias, K. Branigan, V. Jahnke, K. Leder, J. Haas, and J. Heighway Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck Clin Cancer Res 4 10 1998 2411 2418
23. S.L. Holley, J. Heighway, and P.R. Hoban Induced expression of human CCND1 alternative transcripts in mouse Cyl-1 knockout fibroblasts highlights functional differences Int J Cancer 114 3 2005 364 370
24. K.M. Sathyan, K.R. Nalinakumari, T. Abraham, and S. Kannan CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma Oral Oncol 44 7 2008 689 697
25. D.C. Betticher, N. Thatcher, H.J. Altermatt, P. Hoban, W.D. Ryder, and J. Heighway Alternate splicing produces a novel cyclin D1 transcript Oncogene 11 5 1995 1005 1011
26. I. Yaylim-Eraltan, A. Ergen, U. Gormus, S. Arikan, S. Kucucuk, and O. Sahin Breast cancer and cyclin D1 gene polymorphism in Turkish women In Vivo 23 5 2009 767 772
27. C.Y. Cheng, C.S. Chang, C.J. Liu, and S.Y. Kao Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106 1 2008 79 84
28. P.W. Kammerer, T. Toyoshima, S. Eletr, P. Kammerer, K. Kuhr, and B. Al-Nawas Single nucleotide polymorphisms of the vascular endothelial growth factor gene associated with incidence of oral squamous cell carcinoma J Oral Pathol Med 39 10 2010 786 792
29. C. Yapijakis, E. Vairaktaris, S. Vassiliou, A. Vylliotis, E. Nkenke, and A.M. Nixon The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer J Cancer Res Clin Oncol 133 10 2007 787 791
30. E. Vairaktaris, Z. Serefoglou, D. Avgoustidis, C. Yapijakis, E. Critselis, and A. Vylliotis Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer Oral Oncol 45 3 2009 247 253
31. J.L. Formento, M.C. Etienne-Grimaldi, M. Francoual, G. Pages, C. Onesto, and P. Formento Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer Pharmacogenomics 10 8 2009 1277 1283
32. L.H. Wang, S.C. Ting, C.H. Chen, C.C. Tsai, O. Lung, and T.C. Liu Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population J Oral Pathol Med 39 2 2010 155 161
33. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 6 2003 669 676
34. M. Nakamura, Y. Abe, and T. Tokunaga Pathological significance of vascular endothelial growth factor A isoform expression in human cancer Pathol Int 52 5-6 2002 331 339
35. S. Shintani, A. Kiyota, M. Mihara, Y. Nakahara, N. Terakado, and Y. Ueyama Association of preoperative radiation effect with tumor angiogenesis and vascular endothelial growth factor in oral squamous cell carcinoma Jpn J Cancer Res 91 10 2000 1051 1057